Local Chinese hemodialysis equipment has poor competitiveness and low market share. In 2013, China's hemodialysis equipment import dependency rate was about 70%.
Past News ReleasesRSS
Dallas, TX (PRWEB) May 15, 2014
Global and China Hemodialysis Industry Report, 2013-2016 market research says in 2013, the global number of patients receiving dialysis continued to grow to 2.519 million. The new patients mainly come from Asia Pacific region (excluding Japan). Europe, America, Japan and other mature markets already have a higher proportion of patients with advanced renal failure receiving treatment, so they have a slower growth in the number of patients receiving dialysis. For example, in 2013, the number of patients receiving dialysis in Asia-Pacific region grew by 17.0% YoY; while in Japan, EU and US, the number of patients receiving dialysis grew by only 2%-4% YoY. Complete report is available at http://www.chinamarketresearchreports.com/114799.html .
1 Hemodialysis Service Market
Global hemodialysis service market has great regional differences: in Europe and Asia Pacific, public institutions dominate, however, in North America, private-company-operated institutions and in Latin America, private clinics are the main players. Currently, global companies providing hemodialysis service mainly include Fresenius Medical Care, DaVita, etc. The number of patients receiving hemodialysis in these two companies in 2013 came to nearly 340,000.
Dialysis services in China are mainly provided by all levels of hospitals. This is due to the current national health insurance reimbursement ratio, which is relatively low and the affordability of patients is not high. This, in fact results in lower proportion of patients with end-stage renal disease undergoing dialysis treatment, which was only about 12% in 2013. In 2013 the number of Chinese patients with renal failure undergoing dialysis treatment (mainly hemodialysis treatment) was approximately 250,000, and number of patients undergoing peritoneal dialysis was less than 30,000. But with the gradual expansion of China's health insurance coverage at all levels, the proportion of patients with end stage renal disease undergoing treatment will rise sharply and the market prospects will be very promising.
2 Dialysis Equipment Market
The global hemodialysis equipment market is relatively concentrated, mainly dominated by European, American and Japanese companies. The first-tier brands are American and European brands, including Germany-based Fresenius and Braun, U.S.-based Baxter and so on; the second-tier brands mainly are Japanese brands, including NIKKISO, Nipro, Toray and so on. In 2013, market share of Fresenius and Baxter in the global dialysis equipment market reached 34% and 30% respectively.
Companies profiled in Global and China Hemodialysis Industry Report, 2013-2016 include Fresenius Medical Care, NIKKISO, Baxter, Asahi Kasei, Nipro, B. Braun Melsungen AG, Nxstage, Weigao Group, Huaren Pharmaceutical, Guangdong Biolight Meditech, Kelun Pharmaceutical, Jihua Medical Apparatus and Instruments, Bain Medical Equipment, Beijing United Bio-Tech, Jiangsu Lengthen Life Science and Technology and Guangzhou Koncen BioScience. Order a copy of this report at http://www.chinamarketresearchreports.com/contacts/purchase.php?name=114799 .
Local Chinese hemodialysis equipments have poor competitiveness and low market share. In 2013, China's hemodialysis equipment import dependency rate was about 70%. Chinese manufacturers in the field of dialysis include: hemodialysis machine manufacturers like Jihua Medical Apparatus and Instruments Co., Ltd, Guangdong Biolight Meditech Co., Ltd and Chongqing Shanwaishan Science & Technology Co., Ltd; dialyzer manufacturers include Shandong Weigao Group and Jiangsu Lengthen Life Science and Technology Co., Ltd; peritoneal dialysis solution manufacturers include Huaren Pharmaceutical Co., Ltd and Sichuan Kelun Pharmaceutical Co., Ltd.
The "Global and China Hemodialysis Industry Report, 2013-2016" market research includes information on: global hemodialysis population and distribution, etc.; status quo, competition pattern and development trend of the global hemodialysis equipment and service markets; market scale, competition pattern, import & export and development forecasting, etc of China hemodialysis industry; status quo and competition pattern of global and China hemodialysis equipment market segments; operational analysis, hemodialysis business analysis and development forecasting of 16 global and Chinese enterprises in the hemodialysis industry.
Explore more reports on Chinese Life Sciences industry:
China Portable Medical Equipment Industry Report, 2013-2016 market research says with the synergy of favorable policies, improvement in living standards and healthcare awareness raising, China’s portable medical device industry has shown rapid development in recent years, with market size growing at a CAGR of 28.3% in 2008-2013 to approximately RMB44.21 billion in 2013. Complete report is available at http://www.chinamarketresearchreports.com/114793.html .
Research Report on Medical Industry in China, 2014-2018 market study says in China, medical institutions refer to licensed (the Practice License of Medical Institutions) hospitals, health centers, clinics and firstaid stations that diagnose and treat diseases. Demand for medical treatment will increase due to population aging and environment pollution in recent years. It is estimated that investment in medical industry, especially special hospitals of ophthalmology, dentistry and plastic surgery, will increase significantly in the coming years. Complete report is available at http://www.chinamarketresearchreports.com/114778.html .
China Market Research Reports is a database of selected syndicated market reports for global and China industries. Not limited to life sciences (http://www.chinamarketresearchreports.com/cat/life-sciences.html ), ChinaMarketResearchReports.com offers reports on a range of other industries.